Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · December 22, 2016

Subtype Switching and ERBB2/HER2 Amplification/Mutations in Breast Cancer Brain Metastases

JAMA Oncology

 

Additional Info

JAMA Oncology
Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases
JAMA Oncol 2016 Dec 07;[EPub Ahead of Print], N Priedigkeit, RJ Hartmaier, Y Chen, D Vareslija, A Basudan, RJ Watters, R Thomas, JP Leone, PC Lucas, R Bhargava, RL Hamilton, J Chmielecki, SL Puhalla, NE Davidson, S Oesterreich, AM Brufsky, L Young, AV Lee

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading